QUESTIONS ANSWERED
Selank FAQ: Direct Answers from the Research Literature
Twenty-four questions asked about Selank, answered directly from the published peer-reviewed record. Cited where the answer is quantitative.
Identity and use
What does Selank do for you?
Selank is a Russian-developed synthetic heptapeptide (Thr-Lys-Pro-Arg-Pro-Gly-Pro) studied as an anxiolytic and nootropic in rodent and limited human trials. The proposed mechanism involves GABAergic and enkephalin pathways. Russian clinical work reports anxiolytic effects comparable to medazepam in a 62-patient generalized anxiety trial with additional antiasthenic effects [1].
What is Selank?
Selank is a tuftsin analog (TP-7) developed at the Institute of Molecular Genetics of the Russian Academy of Sciences. The sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro extends the immunoglobulin-derived tetrapeptide tuftsin with a Pro-Gly-Pro tripeptide to slow plasma degradation. It is registered as a pharmaceutical in the Russian Federation only and is not FDA-approved [1].
What is Selank peptide used for?
Selank is studied in models of generalized anxiety, stress-induced behavior, and cognitive function, primarily in Russian-literature trials. The principal published indication is anxiolysis; the broader research record includes cognitive protection, BDNF up-regulation, and immunomodulatory effects [1][4][10].
MECHANISM AND PHARMACOKINETICS
Mechanism and pharmacokinetics
How long does Selank take to work?
Intranasal administration produces CNS exposure within minutes in pharmacokinetic studies. Subjective effects in the Russian trial work emerge over the first dosing days of a 7-14 day course [1]. The downstream BDNF mRNA peak in hippocampus is documented at three hours post-dose in rats [4].
Onset of action
Intranasal Selank reaches CNS targets within minutes via olfactory and trigeminal nose-to-brain transport routes. Behavioral readouts in rodent assays emerge within thirty minutes of intraperitoneal dosing [8][17].
REGULATORY STATUS
Regulatory status
Is Selank FDA approved?
No. Selank is registered as a pharmaceutical only in Russia. In the United States it is sold strictly as a research chemical. There is no FDA, EMA, MHRA, or TGA approval for human use.
CONTRAINDICATIONS IN PUBLISHED GUIDANCE
Contraindications in published guidance
Who should not take Selank?
Russian product labeling lists pregnancy and known peptide allergy as contraindications. Outside Russia, Selank is not approved for human use in any jurisdiction. The published trial population (Zozulia 2008) was adults with generalized anxiety disorder and neurasthenia [1].
SAFETY PROFILE IN THE LITERATURE
Safety profile in the literature
Is Selank safe to take?
Russian trials report a benign short-term safety profile across 7-14 day courses [1][10]. Long-term human safety data beyond two-week courses is absent from the published literature. The published record does not document a Selank withdrawal syndrome, and it also does not document chronic-use safety.
Hair loss reports
Does Selank cause hair loss?
No reported association in published trials. User-forum claims of Selank-induced hair loss are anecdotal and not corroborated by the controlled human or rodent literature. The Zozulia (2008) trial did not report dermatological or hair-related adverse events [1].
Effect on sleep
Does Selank help you sleep?
Trials report improved sleep quality secondary to reduced anxiety, not a direct hypnotic effect. The Russian anxiolytic literature framing positions Selank as non-sedating, which is one reason its dosing protocols split daily administration across morning and midday rather than evening [1].
Peptide storage
Does Selank need to be refrigerated?
Reconstituted peptide solutions are typically stored refrigerated. Lyophilized powder is stable at room temperature for short periods. These are general peptide-handling conventions, not Selank-specific clinical guidance — Selank is not sold as a consumer therapeutic outside Russia.